Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Pain Patches Market size was valued at USD 5.39 billion in 2024 and is likely to cross USD 9.79 billion by 2037, expanding at more than 4.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of pain patches is estimated at USD 5.59 billion.
The market expansion is due to the increase in instances of chronic diseases, and the surge in demand for less side effect-prone pain medications. Roughly one in three persons worldwide deal with several chronic illnesses.
In addition to these, it is presumed that the market will grow as a result of a rise in the frequency of trauma injuries from sports and the workplace, including sprains & strains, fractures, tendinitis, and back injuries. Furthermore, an increase in the frequency of occurrences in adults of low back pain is driving the market's expansion.
Pain Patches Sector: Growth Drivers and Challenges
Growth Drivers
- Rising occurrence of chronic pain - According to estimates, the burden of chronic pain has increased to 1.9 billion people worldwide who suffer from recurrent tension-type headaches, the most common symptom of chronic diseases. Therefore, pain patches are used to treat moderate to severe chronic pain when ongoing pain management is necessary for an extended period. As a result, with the number of cases of chronic and other illness-related pain rises, so the demand for pain patches to help patients with pain relief and support market grow.
- Rising aged population - As per the World Health Organization, by 2050, the number of individuals over 80 is expected to triple globally, with the age distribution over 65 years increasing to 36%. This is due to both the aging population and the potential for longer lifespans. Given that 80% of nursing homes and 73% of older people who live in communities report suffering pain regularly, there may be a risk of age-related discomfort. Research indicates that not just chronic pain but also acute pain is not well managed in this group of people.
- Increase in incidence of sport & work-related trauma injuries - In recent years, there has been a sharp increase in the number of people participating in physically demanding sports and jobs and are possibly risky. These elements raise the chances of chronic illnesses like tendinitis and carpal tunnel syndrome as well as acute injuries including fractures, strains, and sprains. There is a direct correlation between the number of people participating in these activities and the risk of injury. There is an increasing need for easy-to-use, non-invasive pain management options as a result of these accidents. By administering medication directly to the site of pain without the need for oral medication or intrusive procedures, pain patches provide a tailored approach to pain management.
Challenges
- Availability of alternatives - Engaging in physical activities can improve efficiency and standard of life while improving safety and reducing the degree of pain. Patients with complex regional pain syndrome with pain and function (CRPS) have been found to benefit from several physical therapy treatments, including graded motor imagery (GMI) and mirror therapy.
Additionally, the benefits of GMI and mirror treatment for phantom limb pain were found. As a result, it is anticipated that the availability of various alternative therapies, including chiropractic adjustments, acupuncture, and pain management devices, will reduce the need for pain patches because they have no negative side effects and will prevent the market from growing. - Limited efficacy may hinder market growth.
- Patent expiration in this field may hamper the growth of the market.
Pain Patches Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.7% |
|
Base Year Market Size (2024) |
USD 5.39 billion |
|
Forecast Year Market Size (2037) |
USD 9.79 billion |
|
Regional Scope |
|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.7% |
|
Base Year Market Size (2024) |
USD 53.65 million |
|
Forecast Year Market Size (2037) |
USD 97.47 million |
|
Regional Scope |
<ul> <li><strong>North America</strong> (U.S., and Canada)</li> <li><strong>Asia Pacific </strong>(Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)</li> <li><strong>Europe</strong> (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)</li> <li><strong>Latin America</strong> (Mexico, Argentina, Brazil, Rest of Latin America)</li> <li><strong>Middle East and Africa</strong> (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)</li> </ul> |
Pain Patches Segmentation
Product Type (Non-Opioid Patches, Opioid Patches)
In pain patches market, non-opioid patches segment is likely to dominate around 60% share by the end of 2037. The increasing demand for opioid substitutes that not only efficiently treat pain but also do so without the risks is accelerating the demand for non-opioid patches. It is also used to provide long-term, efficient medication administration while also easing discomfort. They also avoid the first-pass metabolism and prevent users from becoming addicted to drugs, making them more efficient at delivering pharmaceuticals. Therefore, the market is anticipated to increase as a result of the product's capacity to relieve pain without having the negative effects associated with opioids and other variables. As per the Association for Safe International Travel, over 4.4 million people in the United States needed medical attention due to severe injuries in 2020.
Type (Prescription Medicine, OTC Medicine)
In pain patches market, prescription medicine segment is predicted to dominate around 53% revenue share by the end of 2037. This is because individuals with a broad spectrum of medical conditions may be prescribed pain patches by medical practitioners. They are also commonly used to treat a variety of different types of pain, including knee discomfort, nerve pain, and back pain. Due to its authorization by medical professionals, its use in treating pain from a variety of conditions with little to no negative effects on the patient will accelerate the segment's growth.
Our in-depth analysis of the pain patches market includes the following segments:
|
Product Type |
|
|
Type |
|
|
Distribution Channel |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportPain Patches Industry-Regional Synopsis
North America Market Statistics
By 2037, North America region is projected to hold more than 32% pain patches market share. As per the Centers for Disease Control and Prevention; in 2015, approximately 213 million Americans aged 6 or more participated in sports & fitness activities. With the rising number of people participating in sport-related activities, a significant number of people deal with injuries and thus require pain relief treatment. Pain patches are being considered as the most preferred option for the same.
APAC Market Analysis
During the projected period, the market for pain patches is expected to have significant expansion in the APAC region as well. The population is aging more quickly in the WHO South-East Asia Region. 9.8% of the population in 2017 is 60 years of age or more, by 2030 and 2050, this percentage will increase to 13.7% and 20.3%, respectively. By 2040, the elderly population in China is predicted to account for 28% of the country's total population due to declining birth rates and increased life expectancy. Elderly persons frequently have problems that cause chronic pain because they are more susceptible to a variety of ailments. Because of this, older consumers have a greater need for treatments resulting to the rise in pain patches market in the Asia-Pacific area.
Companies Dominating the Pain Patches Landscape
- Endo, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson and Johnson Private Limited
- Sorrento Therapeutics, Inc.
- Amneal Pharmaceuticals LLC
- Purdue Pharma L.P.
- Teva Pharmaceutical Industries Ltd.
- Grunenthal GmbH
- NEXGEL, Inc.
- Viatris Inc.
- Pfizer Inc.
In the News
- Amneal Pharmaceuticals, Inc. received US FDA approval for an Abbreviated New Drug Application (ANDA) for a generic version of Lidocaine Patch, 5%. The generic form of Lidoderm Patch, 5% is called Lidocaine Patch, 5%, and it is used to treat post-herpetic neuralgia.
- Teva Pharmaceutical Industries Ltd unveiled Flector1 Patch, 1.3 %, an authorized generic. The launch is a breakthrough addition to the company’s product portfolio of more than 40 generic pain management medicines.
Author Credits: Radhika Pawar
- Report ID: 5783
- Published Date: Nov 08, 2024
- Report Format: PDF, PPT
